ResearcherPennsylvania State UniversityActive in the last 2 years
Qing Zhong
Matched on ORCID iD 0000-0001-6979-955X; OpenAlex author ID A5037725750. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 4
- Targeting OFD1 restrains KRAS-driven pancreatic cancer progression by impairing macropinocytosis Co-author DOI 10.21203/rs.3.rs-8939646/v1↗
- OFD1 inhibition induces BRCAness to create a therapeutic vulnerability to PARP inhibition in pancreatic cancer. Last author DOI 10.1038/s41467-025-62295-8↗
- Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells. Co-author DOI 10.1080/15548627.2016.1191722↗
- Cholecystokinin receptor antagonist halts progression of pancreatic cancer precursor lesions and fibrosis in mice. Co-author DOI 10.1097/mpa.0000000000000194↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hanyan Luo · 1 shared paper, 2026 · strength 0.33
- Lingxi Jiang · 1 shared paper, 2025 · strength 0.23
- Peng Li · 1 shared paper, 2025 · strength 0.23
- Baiyong Shen · 1 shared paper, 2025 · strength 0.23
- Renyi Qin · 1 shared paper, 2016 · strength 0.05
- Xingjun Guo · 1 shared paper, 2016 · strength 0.05
- Min Wang · 1 shared paper, 2016 · strength 0.05
- Chengyi Sun · 1 shared paper, 2016 · strength 0.05
- Chengjian Shi · 1 shared paper, 2016 · strength 0.05
- Xu Li · 1 shared paper, 2016 · strength 0.05
- Jianxin Jiang · 1 shared paper, 2016 · strength 0.05
- Jill Palmer Smith · 1 shared paper, 2014 · strength 0.04
- Gail L. Matters · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.